BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Muengtaweepongsa S, Panpattanakul V. Is medical management useful in Moyamoya disease? World J Clin Cases 2024; 12(3): 466-473 [PMID: 38322475 DOI: 10.12998/wjcc.v12.i3.466]
URL: https://www.wjgnet.com/2307-8960/full/v12/i3/466.htm
Number Citing Articles
1
Chaofan Zeng, Haoyuan Chen, Jie Liu, Youyuan Bao, Xudong Sun, Fanbo Meng, Yimeng Xue, Yunhao Cui, Qianjun Zhao, Jing Zhang, Hao Li, Dong Zhang, Rong Wang, Yan Zhang, Guojun Zhang, Jizong Zhao, Qian Zhang. Unraveling the Dyslipidemic Landscape in Moyamoya Disease: OxLDL as a Key BiomarkerCNS Neuroscience & Therapeutics 2025; 31(5) doi: 10.1111/cns.70441
2
Jinpeng Wu, Yifan Xu, Chonghui Zhang, Cuiping Mu, Le Yu, Haowen Xu, Chao Wang, Zhenwen Cui. Development and validation of a predictive model for perioperative low-density lipoprotein as a risk factor for postoperative cerebral infarction in Moyamoya diseaseFrontiers in Neurology 2025; 16 doi: 10.3389/fneur.2025.1602006